News

Filter

Current filters:

Green Cross

Green Cross Neulapeg biosimilar approved in South Korea

28-08-2014

South Korea’s Green Cross says that the country’s Ministry of Food and Drug Safety has granted marketing…

AmgenAsia-PacificBiosimilarsBiotechnologyGreen CrossNeulapegNeulastaOncologyRegulation

BioCryst partner Green Cross gets Korean OK to make and market peramivir flu vaccine

17-08-2010

USA-based BioCryst Pharmaceuticals says that its partner, South Korea-headquartered Green Cross Corp,…

Asia-PacificBioCryst PharmaceuticalsGreen CrossperamivirRegulationRespiratory and PulmonaryVaccines

Back to top